961.14(4)
(4) Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, precursors, analogs, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a)
(a) 3,4-methylenedioxyamphetamine, commonly known as "MDA";
961.14(4)(ag)
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as "MDE";
961.14(4)(am)
(am) 3,4-methylenedioxymethamphetamine, commonly known as "MDMA";
961.14(4)(bm)
(bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known as "DOET";
961.14(4)(g)
(g) 4-methyl-2,5-dimethoxyamphetamine, commonly known as "STP";
961.14(4)(j)
(j) Lysergic acid diethylamide, commonly known as "LSD";
961.14(4)(m)
(m) Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
961.14(4)(mn)
(mn) Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
961.14(4)(t)
(t) Tetrahydrocannabinols, commonly known as "THC", in any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana or chemically synthesized;
961.14(4)(tb)
(tb) Cannabicyclohexonal: 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol.
961.14(4)(te)
(te) CP47,497 and homologues: 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol.
961.14(4)(th)
(th) HU-210: [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c]chromen-1-o1)], also known as (6aR,10aR)-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-
dimethyl-6H-dibenzo[b,d]pyran-9-methanol.
961.14(4)(tL)
(tL) JWH-018: 1-pentyl-3-(1-naphthoyl)indole, also known as Naphthalen-1-yl-(1-pentylindol-3-yl)methanone.
961.14(4)(tp)
(tp) JWH-073): 1-butyl-3-(1-naphthoyl)indole, also known as Naphthalen-1-yl-(1-butylindol-3-yl)methanone.
961.14(4)(tr)
(tr) JWH-081: 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, also known as 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone.
961.14(4)(tu)
(tu) JWH-200: 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole.
961.14(4)(ty)
(ty) JWH-250: 1-pentyl-3-(2-methoxyphenylacetyl)indole, also known as 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone.
961.14(4)(u)
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud)
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug)
(ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur)
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(w)
(w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as "DOB";
961.14(4)(wg)
(wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-B" or "Nexus";
961.14(4)(wgm)
(wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-I".
961.14(4)(wh)
(wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as "2C-T-7";
961.14(4)(wi)
(wi) Alpha-methyltryptamine, commonly known as "AMT";
961.14(4)(wj)
(wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as "5-MeO-DIPT";
961.14(4)(x)
(x) 4-methoxyamphetamine, commonly known as "PMA."
961.14(5)
(5) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag)
(ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or "GHB"), gamma-butyrolactone, and 1,4-butanediol.
961.14(6)
(6) Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:
961.14(7)
(7) Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their precursors, analogs, salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(7)(m)
(m) Methylenedioxypyrovalerone, commonly known as "MDPV."
961.14(7)(n)
(n) 4-methylmethcathinone, commonly known as "mephedrone" or "4-MMC."
961.14(7)(p)
(p) 4-methylthioamphetamine, commonly known as "4-MTA."
961.14(7)(q)
(q) N- benzylpiperazine, commonly known as "BZP."
961.14 History
History: 1971 c. 219;
1981 c. 206; CSB 2.16, 2.15, 2.17, 2.18, 2.19, 2.20;
1989 a. 121; CSB 2.21;
1993 a. 98,
118; CSB 2.22;
1995 a. 225;
1995 a. 448 ss.
157 to
165; Stats. 1995 s. 961.14;
1997 a. 220;
1999 a. 21;
2001 a. 16;
2005 a. 52; CSB 2.31, 2.32, 2.33, 2.34;
2011 a. 31; s. 35.17 correction in (4) (wgm).
961.14 Note
NOTE: See 1979-80 Statutes and 1993-94 Statutes for notes on actions by controlled substances board under s. 161.11 (1), 1993 Stats.
961.14 Annotation
A chemical test need not be specifically for marijuana in order to be probative beyond a reasonable doubt. State v. Wind,
60 Wis. 2d 267,
208 N.W.2d 357 (1973).
961.14 Annotation
Stems and branches supporting marijuana leaves or buds are not "mature stalks" under sub. (14). State v. Martinez,
210 Wis. 2d 396,
563 N.W.2d 922 (Ct. App. 1997),
96-1899.
961.15
961.15
Schedule II tests. 961.15(1m)(1m) The controlled substances board shall add a substance to schedule II upon finding that:
961.15(1m)(b)
(b) The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and
961.15(1m)(c)
(c) The abuse of the substance may lead to severe psychological or physical dependence.
961.15(2m)
(2m) The controlled substances board may add a substance to schedule II without making the findings required under
sub. (1m) if the substance is controlled under schedule II of
21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.15 History
History: 1971 c. 219;
1995 a. 448 ss.
166,
167,
472; Stats. 1995 s. 961.15.
